Takeda Pharmaceutical Company Limited Adjustments For Undistributed Profits Of Investments Accounted For Using Equity Method
Takeda Pharmaceutical Company Limited (TAK) reported Adjustments For Undistributed Profits Of Investments Accounted For Using Equity Method of -JPY 3.99 billion for the 12-month period ending 2025-03-31, per its 20-F filed 2025-06-25.
Financial Statements › Notes
ifrs-full:AdjustmentsForUndistributedProfitsOfInvestmentsAccountedForUsingEquityMethod · last filed 2025-06-25
| Period end | Adjustments For Undistributed Profits Of Investments Accounted For Using Equity Method 12 month |
|---|---|
| 2025-03-31 | -3.99B JPY 20-F · filed 2025-06-25 |
| 2024-03-31 | 6.47B JPY 20-F · filed 2025-06-25 |
| 2023-03-31 | -8.63B JPY 20-F · filed 2025-06-25 |
| 2022-03-31 | -15.37B JPY 20-F · filed 2024-06-26 |